Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease.

• Published in: Seminars in Thrombosis and Hemostasis
• Main Authors: Lassila, Riitta, Holme, Pål André, Landorph, Andrea, Petrini, Pia, Onundarson, Páll T, Hillarp, Andreas
• Other Authors: Unit of Coagulation Disorders, Department of Hematology and Clinical Chemistry Laboratory Services, Helsinki University Central Hospital, Helsinki, Finland. [e-mail]
• Format: Article in Journal/Newspaper
• Language: English
• Published: Thieme 2012
• Subjects: Denmark; Finland; Geography; Hemophilia A; Humans; Iceland; Norway; Practice Guidelines as Topic; Sweden; von Willebrand Diseases
• Online Access: http://hdl.handle.net/2336/227415; https://doi.org/10.1055/s-0031-1281034

To access publisher full text version of this article. Please click on the hyperlink in Additional Links field. Von Willebrand disease (VWD) is the most common inherited bleeding disorder characterized by spontaneous or tissue injury-related, mostly mucocutaneous, bleeding events. VWD affects both males and females and is caused by quantitative or qualitative deficiency of Von Willebrand factor. The diagnostic procedure is complicated because VWD is highly heterogeneous, and differential diagnosis from platelet disorders may be challenging. Moreover, these defects may even coexist, impacting the bleeding phenotype. Mild and moderate VWD can be difficult to distinguish from the normal population, and VWD subtyping may also be problematic. This article summarizes the guidelines of the Nordic Haemophilia Council (NHC), which are intended to serve as a practical tool and provide the standards for diagnosing and treating VWD patients. The complete Nordic Guidelines on VWD are available at the NHC Web site (http://nordhemophilia.org). CSL Behring